Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
29.27
+0.47 (1.63%)
Jul 28, 2026, 1:33 PM EDT - Market open
Genmab Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 979 | 1,204 | 1,326 | 817 | 999.61 | 599.17 |
Depreciation & Amortization | 63 | 71 | 60 | 43 | 52.1 | 37.93 |
Stock-Based Compensation | 116 | 128 | 105 | 85 | 63.19 | 47.41 |
Other Adjustments | 87 | -107 | -337 | -45 | -56.85 | -120.66 |
Change in Receivables | -90 | -166 | -230 | 116 | -305.57 | -154.3 |
Changes in Inventories | -5 | -9 | -1 | -8 | - | - |
Changes in Accounts Payable | -114 | - | - | - | 40.73 | 46.49 |
Changes in Income Taxes Payable | -365 | -460 | -50 | -155 | -227.85 | -113.47 |
Changes in Unearned Revenue | -7 | - | - | - | - | - |
Changes in Other Operating Activities | -63 | 525 | 253 | 218 | -2.3 | -109.65 |
Operating Cash Flow | 601 | 1,186 | 1,126 | 1,071 | 563.06 | 340.72 |
Operating Cash Flow Growth | -25.34% | 5.33% | 5.13% | 90.21% | 65.26% | -67.73% |
Capital Expenditures | -17 | -37 | -27 | -53 | -45.63 | -38.54 |
Purchases of Intangible Assets | - | -18 | -17 | -1 | - | - |
Purchases of Investments | -691 | -995 | -1,256 | -1,582 | -1,396 | -2,388 |
Proceeds from Sale of Investments | 671 | 2,622 | 1,636 | 1,451 | 1,044 | 2,280 |
Cash Acquisitions | - | -7,215 | -1,783 | - | - | - |
Investing Cash Flow | -37 | -5,643 | -1,447 | -185 | -397.4 | -146.96 |
Long-Term Debt Issued | - | 5,500 | - | - | - | - |
Long-Term Debt Repaid | -63 | - | - | - | - | - |
Net Long-Term Debt Issued (Repaid) | -63 | 5,500 | - | - | - | - |
Issuance of Common Stock | 9 | 23 | 19 | 21 | 40.3 | 20.65 |
Repurchase of Common Stock | -543 | -430 | -560 | -81 | -143.36 | -76 |
Net Common Stock Issued (Repurchased) | -534 | -407 | -541 | -60 | -103.06 | -55.36 |
Other Financing Activities | -15 | -304 | -25 | -29 | -10.51 | -8.87 |
Financing Cash Flow | -604 | 4,789 | -566 | -89 | -113.56 | -64.23 |
Foreign Exchange Rate Adjustments | 4 | 3 | 63 | -12 | 82.62 | 129.99 |
Net Cash Flow | -82 | 332 | -887 | 797 | 52.1 | 129.53 |
Free Cash Flow | 584 | 1,149 | 1,099 | 1,018 | 517.44 | 302.18 |
Free Cash Flow Growth | -25.42% | 4.55% | 7.96% | 96.74% | 71.23% | -69.95% |
FCF Margin | 14.97% | 30.89% | 35.21% | 42.59% | 24.78% | 23.48% |
Free Cash Flow Per Share | 1.04 | 1.83 | 1.70 | 1.54 | 0.78 | 0.46 |
Levered Free Cash Flow | 166 | 6,553 | 1,368 | 676 | 601.78 | 274.96 |
Unlevered Free Cash Flow | 352.78 | 941.82 | 1,066 | 641.24 | 525.17 | 163.58 |